Provided by Tiger Trade Technology Pte. Ltd.

Amneal Pharmaceuticals, Inc.

19.65
0.0000
Pre-market: 19.61-0.0400-0.20%04:01 EDT
Volume:3.24M
Turnover:62.95M
Market Cap:6.27B
PE:40.87
High:19.72
Open:19.65
Low:18.97
Close:19.65
52wk High:21.18
52wk Low:9.56
Shares:319.00M
Float Shares:191.00M
Volume Ratio:0.86
T/O Rate:1.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.4808
EPS(LYR):0.2200
ROE:613.02%
ROA:8.60%
PB:189.81
PE(LYR):89.32

Loading ...

Amneal to Report Third Quarter 2026 Results on November 3, 2026

GlobeNewswire
·
Yesterday

Amneal Pharmaceuticals' Biosimilars, Specialty Growth Reshape Earnings Profile, Oppenheimer Says

MT Newswires Live
·
Sep 24

Oppenheimer Initiates Amneal Pharmaceuticals at Outperform With $27 Price Target

MT Newswires Live
·
Sep 23

US Research Roundup- Allstate, Autozone, Vertex Pharmaceuticals

Reuters
·
Sep 23

Update: Amneal Pharmaceuticals Shares Rise After FDA Approval for Lanreotide Injection

MT Newswires Live
·
Sep 22

Top Midday Gainers

MT Newswires Live
·
Sep 22

Amneal Pharmaceuticals up over 11%, on Track for Highest Close Since October 2018

Dow Jones
·
Sep 22

Europe's STOXX 600 Rallies on Tech, Banks Strength as Oil Prices Retreat

Reuters
·
Sep 22

Ipsen Shares Fall After Early Launch of U.S. Generic Rival

Dow Jones
·
Sep 21

Ipsen Falls After US FDA Approves Generic Somatuline

Reuters
·
Sep 21

Analysts Offer Insights on Healthcare Companies: Moderna (MRNA) and Amneal Pharmaceuticals (AMRX)

TIPRANKS
·
Sep 21

Amneal Gets FDA Approval for Generic Hormone Drug

Dow Jones
·
Sep 19

Amneal Pharmaceuticals announces FDA approval and launch of Lanreotide

TIPRANKS
·
Sep 19

Amneal Pharma - FDA Approves Amneal's Lanreotide Injection, 120 Mg/0.5 Ml in a Sterile, Single-Dose Prefilled Syringe

THOMSON REUTERS
·
Sep 19

Amneal Announces FDA Approval and Launch of Lanreotide Injection

THOMSON REUTERS
·
Sep 19

Amneal Pharmaceuticals is Maintained at Overweight by Barclays

Dow Jones
·
Sep 17

Leerink Partners Remains a Buy on Amneal Pharmaceuticals (AMRX)

TIPRANKS
·
Sep 17

Amneal Pharmaceuticals price target raised to $20 from $16 at Barclays

TIPRANKS
·
Sep 17

Amneal Pharmaceuticals Price Target Announced at $23.00/Share by Leerink Partners

Dow Jones
·
Sep 09

Leerink Partners Initiates Coverage on Amneal Pharmaceuticals With Outperform, $23 Price Target

MT Newswires Live
·
Sep 09